共 10 条
[1]
Mill J G,Milanez M da c,Busatto V C,et al.Activation of the cardiac Angiotensin- convertingenzyme after myocardial infarction and its role inventricular rem odeling. Arquivos Brasileiros de Cardiologia . 1997
[2]
Goodfriend T L,Elliotc M E,Cao K J,et al.Angiotensin receptors and their antagonist. The New England Journal of Medicine . 1996
[3]
Timmermans P B M W M,Smith R D.Angiotensin receptor subtypes:Selective antagonists and functionalcorrelates. European Heart Journal . 1994
[4]
Pitt B,Segal R,Martinez F,et al.Randomized trail oflosartan versus captopril in patients over 6 5 with heartfailure (evaluation of losartan in the elderly study,EL ITE). The Lancet . 1997
[5]
Sudhir K,Macgregor J S,Gupta M,et al.Effect ofselective Angiotensin receptor antagonosm andAngiotensin converting engime inhibition on thecoronary vasculative in Vivo- intravascular Two-dimensional and Doppler ultrasound studies. Circulation . 1993
[6]
Goldstein S,Ali A S,Sabbah H,et al.Ventricularrem odeling.Mechanism s and prevention. Cardiology Clinics . 1998
[7]
Wright J W,Harding JW.Brain Angiotensin receptorsubtypes AT1 AT2 and AT3and their functions. Regulatory Peptides . 1995
[8]
Di Pasquale P,Bucca V,Scalzo S,et al.Does theaddition of losartan improve the beneficial effects ofACE inhibitors in patients with anterior myocardialinfarction?A pilot study. Heart . 1999
[9]
Walsh JT,Batin P D,Hawkins M,et al.Ventriculardilatation in the absence of ACE inhibitors:Influence ofhaem odynam ic and neurohorm onal variables followingm yocardial infarction. Heart . 1999
[10]
Solom on S D,Pfeffer M A.Myocardial infarction,ventricular remodeling,and Angiotensin- convertingenzyme inhibition:Where we stand today. American Heart Journal . 1998